Skip to main content
Top
Literature
2.
go back to reference Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004 Jun 3;350(23):2335–42CrossRefPubMed Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004 Jun 3;350(23):2335–42CrossRefPubMed
3.
go back to reference Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23–30. https://doi.org/10.1200/jco.2004.09.046.CrossRef Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23–30. https://​doi.​org/​10.​1200/​jco.​2004.​09.​046.CrossRef
4.
go back to reference Maroney S, de Paz CC, Reeves ME, Garberoglio C, Raskin E, Senthil M et al. Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(3):460–6. https://doi.org/10.1007/s11605-017-3617-5.CrossRef Maroney S, de Paz CC, Reeves ME, Garberoglio C, Raskin E, Senthil M et al. Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(3):460–6. https://​doi.​org/​10.​1007/​s11605-017-3617-5.CrossRef
Metadata
Title
Response to the Letter “Importance of Tumor Burden in the Survival Analyses of Stage IV Colorectal Cancer Patients”
Authors
Naveenraj L. Solomon
Sean Maroney
Carlos Chavez
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 8/2018
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3790-1

Other articles of this Issue 8/2018

Journal of Gastrointestinal Surgery 8/2018 Go to the issue